Lord K A, Wang X M, Simmons S J, Bruckner R C, Loscig J, O'Connor B, Bentley R, Smallwood A, Chadwick C C, Stevis P E, Ciccarelli R B
Department of Molecular and Cellular Biology, Sterling Winthrop Pharmaceutical Research Division, Collegeville, Pennsylvania 19426, USA.
Protein Expr Purif. 1997 Feb;9(1):133-41. doi: 10.1006/prep.1996.0668.
citrate lyase (ACL) is a major generator of cytosolic acetyl-coenzymeA, which is required for both fatty acid and cholesterol biosynthesis. The human ACL (hACL) cDNA was cloned by RT-PCR, and our results indicate the existence of previously unknown sequence variations in hACL. Expression of the hACL cDNA in Spodoptera frugiperda 9 insect cells resulted in the production of high levels of soluble, active enzyme. The recombinant protein (re-hACL) was purified to homogeneity from the soluble lysate of infected cells and was observed to exist as a tetramer by gel filtration chromatography. Kinetic analyses indicated that the re-hACL and rat ACL have very similar enzymological properties. The facile preparation of milligram quantities of purified, active re-hACL affords the opportunity to characterize the enzyme for structure-based design of hypolipidemic drugs, and to further examine the functional significance of the sequence variations.
柠檬酸裂解酶(ACL)是胞质乙酰辅酶A的主要生成者,而脂肪酸和胆固醇生物合成均需要胞质乙酰辅酶A。通过逆转录聚合酶链反应(RT-PCR)克隆了人ACL(hACL)cDNA,我们的结果表明hACL中存在以前未知的序列变异。hACL cDNA在草地贪夜蛾9昆虫细胞中的表达导致产生了高水平的可溶性活性酶。重组蛋白(re-hACL)从感染细胞的可溶性裂解物中纯化至同质,通过凝胶过滤色谱法观察到其以四聚体形式存在。动力学分析表明,re-hACL和大鼠ACL具有非常相似的酶学性质。轻松制备毫克量的纯化活性re-hACL为基于结构的降血脂药物设计表征该酶以及进一步研究序列变异的功能意义提供了机会。